CacheTech Inc’s AbbVie ABBV Stock Holding History

CacheTech Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	4,610 +1,645	+55%	+$354K	0.19%	87
2026 Q1	$645K	Buy	2,965 +195	+7%	+$43.3K	0.12%	102
2025 Q4	$633K	Sell	2,770 -162	-6%	-$36.9K	0.12%	115
2025 Q3	$679K	Sell	2,932 -394	-12%	-$80.2K	0.14%	85
2025 Q2	$617K	Sell	3,326 -1,613	-33%	-$300K	0.11%	89
2025 Q1	$1.03M	Sell	4,939 -339	-6%	-$65.9K	0.2%	66
2024 Q4	$938K	Buy	5,278 +565	+12%	+$104K	0.18%	67
2024 Q3	$931K	Sell	4,713 -301	-6%	-$56.2K	0.2%	62
2024 Q2	$860K	Buy	+5,014	New	+$831K	0.2%	58

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CacheTech Inc's ABBV Position: Q2 2026 in Review

CacheTech Inc increased its AbbVie (ABBV) stake by 55% in Q2 2026, buying an estimated $354K and bringing the position to 4,610 shares worth $1.16M. The position accounts for 0.19% of the portfolio, ranked #87.

CacheTech Inc first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

CacheTech Inc held 4,610 shares of AbbVie worth $1.16M as of Q2 2026.
CacheTech Inc bought 1,645 AbbVie shares in Q2 2026, an estimated $354K.
AbbVie made up 0.19% of CacheTech Inc's portfolio in Q2 2026, its #87 holding.
CacheTech Inc first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CacheTech Inc's 13F filing for Q2 2026, filed 11 Aug 2026.